Safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease-Results of a multicenter open trial.

Kenichi KashiharaTetsuya MaedaKazuto Yoshida

Published in: Neuropsychopharmacology reports (2022)

Significant improvements in hallucinations and delusions can be expected, although aripiprazole may aggravate parkinsonism in Parkinson's disease patients. Low-dose use of aripiprazole may be useful for managing Parkinson's disease patients with psychosis, but only with close observation of extrapyramidal symptoms.

Keyphrases

low dose
end stage renal disease
newly diagnosed
minimally invasive
study protocol
peritoneal dialysis
physical activity
phase iii
double blind
phase ii
sleep quality
patient reported